The Limited Times

Now you can see non-English news...

Covid: Argentina, agreement for Chinese Sinopharm vaccine

2021-01-10T10:04:40.015Z


19. (ANSA) The government of Argentina is in the process of finalizing the purchase by the end of January of one million doses of the vaccine produced by the Chinese state-owned company Sinopharm. Loris today the Telam news agency.     Since the end of December, the Argentine authorities have started a vaccination campaign, which has affected over 100,000 people, using the Russian product Sputnik V, of whic


The government of Argentina is in the process of finalizing the purchase by the end of January of one million doses of the vaccine produced by the Chinese state-owned company Sinopharm.

Loris today the Telam news agency.


    Since the end of December, the Argentine authorities have started a vaccination campaign, which has affected over 100,000 people, using the Russian product Sputnik V, of which an additional important quantity is imminent in Buenos Aires.


    Sources aware of the negotiations with Beijing have revealed that the vaccine, also known as belonging to the China National Biotech Group, should arrive in Argentina in the last days of January.


    The negotiation with Sinopharm, the sources added, was started after an exchange of letters between the presidents of China and Argentina, Xi Jinping and Alberto Fernández, regarding the strengthening of bilateral cooperation in the health field against Covid-19.


    For his part, confirming the arrival of the vaccine, the Argentine Minister of Health, Ginés González García, announced that negotiations are also advanced to import another vaccine from China, Sinovac, manufactured in Brazil by the Butantan Institute of San Paolo. (HANDLE).


Source: ansa

All life articles on 2021-01-10

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.